Notice of Effectiveness · EFFECT
Rallybio Corporation
RLYBNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-10-15
- Effective time (as filed)
- 09:30:00
- Form
- S-4
Registrant 1
- Registrant
- Rallybio Corp
- Registrant CIK
- 0001739410
- File number
- 333-297483
Company context
Rallybio (Nasdaq: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of complement dysregulation and hematology.